Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optomel is a photonics company specializing in the development of advanced optical filters and materials for the life sciences and diagnostic sectors. The company's proprietary Omni-Filter technology leverages liquid crystal materials to provide high-performance, customizable optical solutions for applications such as fluorescence microscopy and point-of-care testing. By offering scalable and cost-effective filtering components, Optomel enhances the capabilities of medical imaging and analytical instrumentation. Their products are designed to replace traditional thin-film filters with more flexible and robust alternatives. Headquartered in Southampton, UK, the company is a spin-out from the University of Southampton. Optomel serves a global client base, providing critical components for both research and clinical diagnostic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optomel.